Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Raherison-Semjen (Pessac, France). COPD severity using GOLD 2017 in real life: The French Palomb Cohort. 1210

Member's Comments

No comment yet.

Related content which might interest you: Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Validation of the GOLD 2017 classification in a Chinese COPD cohort Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 GOLD Stage I and II patients in European Health-related Quality of Life in COPD study Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Does one year change in quality of life predict the mortality in patients with COPD?: Prospective cohort study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 LATE-BREAKING ABSTRACT: GOLD 2011: Combined COPD assessment of patients from the European health-related quality of life study Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Health state and the quality of life in patients with chronic obstructive pulmonary disease (COPD) in Poland: A study using the EuroQoL-5D questionnaire Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Source: International Congress 2015 – Latest insights into chronic care Year: 2015